Cargando…
Development of Stable Chimeric IL-15 for Trans-Presentation by the Antigen Presenting Cells
IL-15 is one of the important biologics considered for vaccine adjuvant and treatment of cancer. However, a short half-life and poor bioavailability limit its therapeutic potential. Herein, we have structured IL-15 into a chimeric protein to improve its half-life enabling greater bioavailability for...
Autores principales: | Patidar, Manoj, Yadav, Naveen, Dalai, Sarat K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092395/ https://www.ncbi.nlm.nih.gov/pubmed/33953717 http://dx.doi.org/10.3389/fimmu.2021.646159 |
Ejemplares similares
-
Liver-Stage Specific Response among Endemic Populations: Diet and Immunity
por: Dalai, Sarat Kumar, et al.
Publicado: (2015) -
Corrigendum: Liver-Stage Specific Response among Endemic Populations: Diet and Immunity
por: Dalai, Sarat Kumar, et al.
Publicado: (2015) -
Memory CD8 T Cells Specific for Plasmodia Liver-Stage Antigens Maintain Protracted Protection Against Malaria
por: Krzych, Urszula, et al.
Publicado: (2012) -
IL-15Rα chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation
por: Mortier, Erwan, et al.
Publicado: (2008) -
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
por: Huntington, Nicholas D., et al.
Publicado: (2009)